Mycobacterium tuberculosis Sub-Lineage 4.2.2/SIT149 as Dominant Drug-Resistant Clade in Northwest Ethiopia 2020–2022: In-silico Whole-Genome Sequence Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mycobacterium tuberculosis Sub-Lineage 4.2.2/SIT149 as Dominant Drug-Resistant Clade in Northwest Ethiopia 2020–2022: In-silico Whole-Genome Sequence Analysis

Published:2023-10 Issue: Volume:Volume 16 Page:6859-6870
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Mekonnen Daniel^ORCID,Munshea Abaineh,Nibret Endalkachew^ORCID,Adnew Bethlehem,Getachew Hailu,Kebede Amiro,Gebrewahid Ananya,Herrera-Leon Silvia,Amor Aramendia Aranzazu^ORCID,Benito Agustín,Abascal Estefanía,Jacqueline Camille,Aseffa Abraham^ORCID,Herrera-Leon Laura

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference64 articles.

1. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

2. World Health Organization. WHO Consolidated Guidelines on Tuberculosis: Module 4: Treatment -Drug-Resistant Tuberculosis Treatment 2022 Update. Geneva: World Health Organization; 2022.

3. Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis

4. Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis

5. World Health Organization. Global Tuberculosis Report 2022. Geneva: World Health Organization; 2022.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic and Genotypic Drug Resistance of Mycobacterium tuberculosis Strains Isolated from HIV-Infected Patients from a Third-Level Public Hospital in Mexico;Pathogens;2024-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP